Member Info for ZzTop1

And another thing to be glad about is there's no more approximate timetable for news releases. No more 3 weeks for this and 2 weeks for that. Less volatility because of it? Let's see.

No note from Barry Gibb @ Turner Pope today unless I missed it?

Yes nice post, Sleepy, thanks.

Summer 2020 in Northern Hemisphere began on
Saturday, 20 June
and ends on
Tuesday, 22 September
All dates are in United Kingdom Time.

Still all looking good for this summer

This, combined with other collaborations that we are putting in place, will provide us with access to a sufficient number of COVID-19 patient samples to allow us to quickly clinically validate the saliva rapid test.

The mention of other collaborations in the RNS for the rapid test is very interesting. I wonder if these would be UK based or perhaps US.. The strip's ready and ready to go! I suspect many will take positions ahead of test results being announced. Gla!

Let's not dwell on this.. It should be clear to all, whether experienced or new that these boards are littered with groups and individuals who will use scare tactics to their advantage. I think Global more than understands the basics.

Back to Avacta - The LFD tests are a potential game changer. We all know if the gold standard is achieved then the global demand for such a product will blow the lid off this sp. Hold tight, Avacta, partners and governments are acutely aware of what is at stake.

Great Post BBN, thank you.

As we've already been told, there is ongoing discussion on the compression of the normal manufacturing, clinical validation and regulatory timeliness. I expect we'll hear more on this when we hear on lfd optimisation.

News has been previously consistent with when AS has said it would arrive so I would go with this week too. Some interesting SP movements last 3 trading days too

It would seem so Doggy.

If Gerry is speaking with companies in the cruise line industry could AS and Avacta be involved with discussions too, offering up "human tests" to compliment novel sensors? Wouldn't rule it out.

Understand what you're saying G-Man although still firmly believe that fast, accurate testing is vital for any global return to normality. Face masks in shops, cinemas without that buzz of old, children playing football at 1 metre apart... Every aspect of day to day life is affected. A high quality test is needed now more than ever and will continue to be required even as we learn to adjust to the virus.

I'm quite sure most if not all current holders will assess their investment strategy following the expected news flow over the next few weeks.

Volatility whilst we wait for news should be no surprise. Some complete bells on the bb today thinking they cab influence sp spouting crap.

Latest Turner Pope note said 3 weeks or so for optimisation and that was last week so nothing new here

I think I know where the insight's plucked from!

I hope you're right anyway Happy Hardcore, besides Medusa19 must be waiting so anxiously whilst investing and not knowing if there'll be a saleable product soon or not :)

Yes nasal swab. 84.38% sensitivity - I think Avacta shooting for >90%

Apologies for any confusion Blownitalready. My message is just general advice to all which follows on from your sound original message

Please stop replying to these feckers and let their poison threads move down the board, out of sight. They feed off responses

Bad news indeed and unfortunately more regional lockdowns to follow globally.

It's been said before, please refrain from replying to messages with negative subjects. These idiots just want the subject header staying as high as possible.

Not much we can do apart from buy more at £1 if it hits ;)

Agree, nothings changed including Avacta market cap of £290m. Having read again the (19th May) 'Avacta Group “Affimers First-Class Prospects” says Zeus Capital' article I am comfortable with the current share price. Taken from the article:
-------
Avacta Group has promising Therapeutic and Diagnostics pipelines; we suggest a base case valuation of AVCT of £290m. There is clearly enormous upside from a successful rollout of SARS COV-2 tests. Even executing a fraction of this potential in FY20 would be transformational, providing cash resource to advance its promising Therapeutics pipeline. Applying market metrics it also implies that a £ multi-billion valuation of AVCT is achievable on execution.
-----
I have full confidence in Avacta executing and like AS said himself he wouldn't go after this if he wasn't confident too.

Thank you Ophidian. The fall below £1 was a test for all. Your contributions are invaluable in reminding us that this is indeed a process which is being massively accelerated through the hard work put in by Avacta and partners. Patience now is key, ignore the daily movements and the noise from non holders on this board

Turner Pope giving it 3 or so weeks for optimisation. We will know soon enough and if we remain confident the test strip will be high performing then AS continues to push on the manufacturing side. Pieces falling together nicely.

Barcode why are you so helpful here if you don't own shares I'm assuming?